
    
      Patients referred from dentists and physicians in the period 1993 to 1999 to the Dental
      Biomaterials Adverse Reaction Unit, Department of Health, UNIFOB AS, for symptoms related to
      amalgam restorations are randomized into treatment group (n=20) or reference group (n=20).
      All patients in the treatment group are followed 3, 12, 36 and 60 months after completion of
      amalgam removal with questionnaires on health outcomes, Minnesota Multiphasic Personality
      Inventory-2 (MMPI-2) and laboratory tests.
    
  